P
Peter K. Lindenauer
Researcher at University of Massachusetts Medical School
Publications - 352
Citations - 13985
Peter K. Lindenauer is an academic researcher from University of Massachusetts Medical School. The author has contributed to research in topics: Retrospective cohort study & Pneumonia. The author has an hindex of 55, co-authored 322 publications receiving 12278 citations. Previous affiliations of Peter K. Lindenauer include Miriam Hospital & The Joint Commission.
Papers
More filters
Journal ArticleDOI
Public Reporting and Pay for Performance in Hospital Quality Improvement
Peter K. Lindenauer,Denise Remus,Sheila Roman,Michael B. Rothberg,Evan M. Benjamin,Allen Ma,Dale W. Bratzler +6 more
TL;DR: Hospitals engaged in both public reporting and pay for performance achieved modestly greater improvements in quality than did hospitals engaged only in public reporting.
Journal ArticleDOI
Perioperative beta-blocker therapy and mortality after major noncardiac surgery.
Peter K. Lindenauer,Penelope S. Pekow,Kaijun Wang,Dheeresh K. Mamidi,Benjamin Gutierrez,Evan M. Benjamin +5 more
TL;DR: Perioperative beta-blocker therapy is associated with a reduced risk of in-hospital death among high-risk, but not low- risk, patients undergoing major noncardiac surgery and patient safety may be enhanced by increasing the use of Beta-blockers in high- risk patients.
Journal ArticleDOI
Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007.
Tara Lagu,Michael B. Rothberg,Meng-Shiou Shieh,Penelope S. Pekow,Jay S. Steingrub,Peter K. Lindenauer +5 more
TL;DR: The increase in the number of hospitalizations for severe sepsis coupled with declining in-hospital mortality and declining geometric mean cost per case may reflect improvements in care or increases in discharges to skilled nursing facilities; however, these findings more likely represent changes in documentation and hospital coding practices that could bias efforts to conduct national surveillance.
Journal ArticleDOI
Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery.
TL;DR: Treatment with lipid-lowering agents may reduce risk of death following major noncardiac surgery and clinical trials are required to confirm this observation.
Journal ArticleDOI
Perioperative beta-blocker therapy and mortality after major noncardiac surgery
TL;DR: Perioperative beta-blocker therapy is associated with a reduced risk of in-hospital death among high- risk, but not low-risk, patients undergoing major noncardiac surgery and patient safety may be enhanced by increasing the use of beta- blockers in high-risk patients.